Caspase cleavage of HER-2 releases a Bad-like cell death effector.


Human epidermal growth factor receptor-2 (HER-2/ErbB2/neu), a receptor tyrosine kinase that is amplified/overexpressed in poor prognosis breast carcinomas, confers resistance to apoptosis by activating cell survival pathways. Here we demonstrate that the cytoplasmic tail of HER-2 is cleaved by caspases at Asp(1016)/Asp(1019) to release a approximately 47-kDa product, which is subsequently proteolyzed by caspases at Asp(1125) into an unstable 22-kDa fragment that is degraded by the proteasome and a predicted 25-kDa product. Both the 47- and 25-kDa products translocate to mitochondria, release cytochrome c by a Bcl-x(L)-suppressible mechanism, and induce caspase-dependent apoptosis. The 47- and 25-kDa HER-2 cleavage products share a functional BH3-like domain, which is required for cytochrome c release in cells and isolated mitochondria and for apoptosis induction. Caspase-cleaved HER-2 binds Bcl-x(L) and acts synergistically with truncated Bid to induce apoptosis, mimicking the actions of the BH3-only protein Bad. Moreover, the HER-2 cleavage products cooperate with Noxa to induce apoptosis in cells expressing both Bcl-x(L) and Mcl-1, confirming their Bad-like function. Collectively, our results indicate that caspases activate a previously unrecognized proapoptotic function of HER-2 by releasing a Bad-like cell death effector.

DOI: 10.1074/jbc.M802156200


Citations per Year

682 Citations

Semantic Scholar estimates that this publication has 682 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Strohecker2008CaspaseCO, title={Caspase cleavage of HER-2 releases a Bad-like cell death effector.}, author={Anne M. Strohecker and Fruma Yehiely and Feng Chen and Vincent L Cryns}, journal={The Journal of biological chemistry}, year={2008}, volume={283 26}, pages={18269-82} }